Twist Bioscience Corporation (TWST) Tops Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Reports Second Quarter 2022 Financial Results
May 5, 2022 4:05 PM EDT-- Record revenue of $48.1M in 2QFY22; Increase of 54% over $31.2M in Fiscal 2021
-- Orders Increased 32% in 2QFY22 over Fiscal 2021 to $55.0M --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality... More



